H. Bedier, S. Isnard, C. Maedler-Kron, and J.-P. Routy, “Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19”, EJCRIM, vol. 10, no. 12, Nov. 2023.